The acquisition would boost Aurora's market capitalization to more than $3 billion and would see it serve about 40,000 active registered patients. That compares to 63,000 at Canopy Growth Corp. (TSX:WEED), Canada's largest marijuana company. "This is all about creating a fully integrated, globally dominant cannabis company and that's what we can achieve together," Battley said. Canadian marijuana companies have ramped up production capacity ahead of Canada's deadline for the legalization of recreational cannabis next summer and worked to extend their reach outside the country's borders over the last financial quarter. Some analysts have been predicting a wave of consolidation among the around 50 licensed producers in the burgeoning industry ahead of legalization.